Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype C0018801|heart failure
Sentences 43
PubMedID- 20185412 Renal revascularization for heart failure in patients with atherosclerotic renovascular disease.
PubMedID- 25775120 Atrial fibrillation (af) and heart failure (hf) are two of the most common cardiovascular diseases.
PubMedID- 22102784 There have been a number of studies of arbs in patients at the end of the cardiovascular disease continuum, ie, in patients with heart failure or left ventricular systolic dysfunction.
PubMedID- 22763481 Dietary salt restriction is recommended for the prevention of cardiovascular disease in patients with hypertension and heart failure as well as in the general population.
PubMedID- 25492141 Hypertension and coronary heart disease were the basic cardiovascular diseases combined with heart failure in the various ethnic groups in xinjiang.
PubMedID- 20498206 These data were used to compute comparative age-, sex- and calendar year-specific hospitalisation rates for each category of vascular disease excluding heart failure (data on this outcome in the general population were unavailable).
PubMedID- 26268323 (4) cardiovascular diseases including patients with decompensated heart failure.
PubMedID- 26443101 The patient background characteristics included age, sex, and specific co-morbidities including liver cirrhosis, cardiac diseases (ischemic heart disease, pulmonary embolism, endocarditis, or heart failure), history of cerebrovascular diseases (cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage), lung diseases (chronic obstructive pulmonary disease, emphysema, chronic bronchitis, asthma, pneumonia, or respiratory failure), and renal failure.
PubMedID- 25276705 Introduction: heart failure is one of the most common cardiovascular diseases which decrease the quality of life.
PubMedID- 21559185 The diseases that most often drive the elderly to apply for an urgent evaluation are cardiovascular diseases (angina, heart failure, arrhythmias, and syncope) or respiratory diseases (acute exacerbation of chronic bronchitis, bronchial asthma, and pneumonia), in addition, cancer (cancer of the lung, breast, and large bowel), and neurological diseases (acute cerebrovascular disease, altered state of consciousness) [4].
PubMedID- 21858050 On the other hand, hypophosphatemia can also cause cardiovascular disease including heart failure after cardiac surgery and cardiac arrest in patients undergoing treatment for diabetic ketoacidosis with hypertriglyceridemia [11], [12].
PubMedID- 24462554 Background: although the transpulmonary gradient (tpg) and pulmonary vascular resistance (pvr) are commonly used to differentiate heart failure patients with pulmonary vascular disease from those with passive pulmonary hypertension (ph), elevations in tpg and pvr may not always reflect pre-capillary ph.
PubMedID- 21776309 The united states spends about dollar 20 billion annually, 10% of healthcare budget allocated for the management of cardiovascular disease with heart failure, 75% of the amount being allocated to hospital care.
PubMedID- 24599246 Moreover, some of these studies clearly reported a positive correlation between the frequency of circulating leukocytes or leukocyte subsets with adverse outcome in cad patients or in apparently healthy individuals with perivascular disease or in patients with heart failure [7], [9], [10], [13]–[17].
PubMedID- 22508558 Aims: to investigate the prognostic impact of atherosclerotic renovascular disease in patients with chronic heart failure.
PubMedID- 25893874 Soluble flt-1 links microvascular disease with heart failure in ckd.
PubMedID- 22140319 In the transcend trial, 5926 high-risk patients intolerant to ace inhibitors, but otherwise similar to ontarget population, were randomized to receive telmisartan 80 mg/day or placebo.16 after 56 months, telmisartan did not reduce a composite endpoint of cardiovascular death, myocardial infarction, stroke, or hospitalization for heart failure in patients with cardiovascular disease or diabetes with end-organ damage (telmisartan 15.7%, placebo 17%, hazard ratio [hr]: 0.92; 95% ci: 0.81–1.05, p = 0.216).
PubMedID- 21981559 Background: the recently published ontarget trial found that telmisartan was non-inferior to ramipril in reducing cv death, mi, stroke, or heart failure in patients with vascular disease or high-risk diabetes.
PubMedID- 21603275 There is consistent evidence that elevated sympathetic nervous activity predicts mortality in cardiovascular disease such as in patients with heart failure [111] and end-stage renal disease [112, 113].
PubMedID- 24775822 heart failure is the end-stage of many cardiovascular diseases-such as acute myocardial infarction-and remains one of the most appealing challenges for regenerative medicine because of its high incidence and prevalence.
PubMedID- 26221650 When untreated, this cardiomyopathy can lead to heart failure, one of many cardiovascular diseases (cvds).
PubMedID- 24278681 heart failure is one of the few cardiovascular diseases whose prevalence continues to rise, largely related to the aging population accompanied by improved survival in patients with heart failure and following myocardial infarction [1, 2].
PubMedID- 23935815 Therefore, we included cardiovascular diseases that lead to heart failure such as rheumatic heart disease as outcomes for sbp, but the reported rrs should only be applied to mortality from these causes (as opposed to incidence) because the incidence of diseases like rhd and other inflammatory heart diseases is unlikely to be affected by sbp.
PubMedID- 21411741 Background: pulmonary vascular disease associated with left-side heart failure and preserved ejection fraction (ph-hfpef) is an increasingly common cause of pulmonary hypertension.
PubMedID- 23690809 Furthermore, the age of exposure to cardiovascular disease, mainly heart failure, is decreasing in iran and is reaching the teenage years.
PubMedID- 22254454 Heartcycle is a large-scale eu integrated project aiming to provide a complete disease management solution for cardiovascular disease patients, with emphasis on heart failure (hf) and coronary artery disease (cad) patients.
PubMedID- 23403406 Patients were followed for 1-9 years for all-cause mortality and cardiovascular disease with myocardial infarction, heart failure and stroke.
PubMedID- 23472116 Furthermore, aging and underlying cardiovascular risk factors [5], such as diabetes and heart failure [6] in patients with cardiovascular diseases affect the number and capacity of their circulating bm-derived progenitor cells [7], [8] which further hamper the effectiveness of autologous bm cell therapy.
PubMedID- 21716684 On the other hand, cardiovascular disease including heart failure is common in patients with renal failure, and cardiovascular death is the leading cause of mortality among renal cohorts [10].
PubMedID- 21873564 For the purposes of the current study, 33 participants were excluded because of prevalent cardiovascular disease: 2 with history of heart failure, 11 with prevalent coronary artery disease, 6 with previous stroke, 1 who had underwent previous valve replacement, and 13 with echocardiographic evidence of significant valve disease (aortic or mitral stenosis or regurgitation more than mild).
PubMedID- 25905105 Despite the improved treatment of cardiovascular diseases, the population with end-stage heart failure (hf) is progressively growing.
PubMedID- 22943191 Recent guidelines do not include hr as prognostic marker, as the prognostic significance of hr in right heart failure due to pulmonary vascular disease had not been sufficiently studied [9,16].
PubMedID- 20441018 Background: chronic heart failure is one of the most important cardiovascular diseases.
PubMedID- 20231536 Conclusions: ed is a potent predictor of all-cause death and the composite of cardiovascular death, myocardial infarction, stroke, and heart failure in men with cardiovascular disease.
PubMedID- 22971785 In recent studies on cardiac gene expression in various experimental models of cardiovascular diseases associated with heart failure, kuwahara and nakao [16] identified a series of “transcriptional pathways” involved in cardiac remodeling and connected to the reactivation of fetal cardiac genes implicated in the genesis of myocardial hypertrophy and severe cardiac rhythm disorders.
PubMedID- 22893246 Cardiovascular disease, including heart failure, is a principal cause of death in individuals with obesity and diabetes.
PubMedID- 23495547 heart failure is one of the fastest growing cardiovascular diseases of the 21st century.
PubMedID- 24286578 heart failure is one of the most prevalent cardiovascular diseases in the united states, and is associated with significant morbidity, mortality, and costs.
PubMedID- 25172361 Background: there is increasing interest in utilising novel markers of cardiovascular disease risk in patients with chronic heart failure (hf).
PubMedID- 24292636 Background: left ventricular hypertrophy (lvh) is an independent risk factor for cardiovascular disease and is associated with heart failure development.
PubMedID- 26543825 Cardiovascular disease, including heart failure (hf), is the major cause of death in patients with diabetes.
PubMedID- 21254742 The united states spends about 20 billion dollars annually, 10% of healthcare budget allocated for the management of cardiovascular disease with heart failure, 75% of the amount being allocated to hospital care.
PubMedID- 21138571 Exclusion criteria for all subjects included malignancy, rheumatoid disease, diabetes mellitus, maintenance oral corticosteroids, active infection or other chronic inflammatory disease, weight losing drugs, known congestive heart failure, documented history of cardiovascular disease, solid organ transplantation, parallel participation in interventional study, pregnancy or breastfeeding.

Page: 1